Acadian Asset Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Acadian Asset Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,656	Closed	-$271K	–	1888
2016 Q3	$271K	Sell	14,656 -8,599	-37%	-$149K	﹤0.01%	920
2016 Q2	$378K	Sell	23,255 -5,388	-19%	-$90.8K	﹤0.01%	818
2016 Q1	$405K	Sell	28,643 -194,037	-87%	-$2.62M	﹤0.01%	787
2015 Q4	$3.8M	Buy	222,680 +130,941	+143%	+$2.55M	0.02%	441
2015 Q3	$1.9M	Buy	+91,739	New	+$1.88M	0.01%	560

Other funds holding NDRM

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management's NDRM Position: Q4 2016 in Review

Acadian Asset Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 14,656 shares — an estimated $271K sold.

Acadian Asset Management first reported a position in NDRM in Q3 2015 and held it in 5 quarters. The position peaked at $3.8M in Q4 2015. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

Acadian Asset Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
Acadian Asset Management sold 14,656 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $271K.
Acadian Asset Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 5 quarters.
Acadian Asset Management's NeuroDerm Ltd. Ordinary Shares position peaked at $3.8M in Q4 2015.
56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on Acadian Asset Management's 13F filing for Q4 2016, filed 19 Jan 2017.